High- or low-salt diet from weaning to adulthood: Effect on insulin sensitivity in Wistar rats

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 424-429

  De Prada, Patrícia O ^b   Okamoto, Maristella M ^b   Furukawa, Luzia Naôko S ^b   Machado, Ubiratan Fabres ^b   Heimann, Joel C ^b   Dolnikoff, Miriam Sterman ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Angiotensin; Captopril; Insulin; Insulin resistance; Sodium, dietary

Indexed keywords

CAPTOPRIL; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; RENIN; SODIUM CHLORIDE;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM RESTRICTION; WEANING;

EID: 0033958124     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.424     Document Type: Conference Paper

References (37)

1. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin resistant state. J Cardiovasc Pharmacol. 1990;15(suppl 5):S18-S25.
2. De Fronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
3. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
4. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J. 1993;306: 983-987.
5. World Hypertension League. Nonpharmacological interventions as an adjunct to the pharmacological treatment of hypertension: a statement by WHL. J Hum Hypertens. 1993;7:159-164.
6. Sakurai J, Ogawa N, Ooda S, Gomi T, Ikeda T. Effect of sodium balance on insulin sensitivity in essential hypertension. J Hypertens. 1994;12: S243-S245.
7. Fliser D, Fode P, Arnold U, Nowicki M, Khol B, Ritz E. The effect of dietary salt on insulin sensitivity. Eur J Clin Invest. 1995;25:39-43.
8. Donovan DS, Solomon CG, Seely EW. Effect of sodium intake on insulin sensitivity. Am J Physiol. 1993;264:E730-E734.
9. Lima NKC, Lima FB, Santos EA, Okamoto MM, Matsushita DH, Hell NS, Heimann JC. Chronic sodium chloride overload increases blood pressure and improves metabolism, without changing insulin sensitivity. Am J Hypertens. 1997;10:720-727.
10. De Fronzo R, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phvsiol. 1979;237: E214-E223.
11. Stanbie D, Brownsy RW, Crettaz M, Denton RM. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J. 1976;160:413-416.
12. Machado UF, Shimizu Y, Saito M. Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice. Physiol Behav. 1994;55:621-625.
13. Papa PC, Seraphim PM, Machado UF. Loss of weight restores GLUT4 content in insulin-sensitive tissues of monosodium-treated obese mice. Int J Obesity. 1997;21:1065-1070.
14. Catanozi AS, Passarelli M, Rocha JC, Silva AA, Nakadakare ER, Mesquita CH, Harada LM, Dolnikoff MS, Heimann JC, Quintão ECR. Low salt consumption increases plasma triglyceride despite a normal production rate. Am J Hypertens. 1998;11:208A. Abstract 46.
15. Moan A, Hoieggen A, Nordby G, Eide K, Kjeldsen SE. Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity. J Hum Hypertens. 1995;9(suppl 5):S45-S50.
16. Lerch M, Teuscher AU, Beissner P, Schneider M, Shaw SG, Weidmann P. Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents. J Cardiovasc Pharmacol. 1998;31:576-580.
17. Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L, Asagami T, Hino T, Saito F, Otsuka Y, Kurumatani H, Kobayashi F, Kanmatsuse K, Kajiwara N. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin-converting enzyme inhibitor. Hypertension. 1994;23:450-455.
18. Carvalho CRO, Thirone ACP, Gontijo JAR, Velloso LA, Saad MJA. Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes. 1997;46:1950-1957.
19. Iyer SN, Katovich MJ. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats. Am J Hypertens. 1996;9:662-668.
20. Henriksen EJ, Jacob S. Effects of captopril transport activity in skeletal muscle of obese Zucker rats. Metabolism. 1995;44:267-272.
21. Henriksen EJ, Jacob S, Fogt DL, Dietze GJ. Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance. Am J Physiol. 1998;275:R40-R45.
22. Erdös E. Angiotensin I converting enzyme. Circ Res. 1975;36:247-255.
23. 9) BK in carrageenan-induced edema. Peptides. 1996;17:1009-1015.
24. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkubo Y, Miyamura N, Miyata T, Yano T, Shichiri M. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bra dykinin may improve insulin resistance in dogs and humans. Diabetologia. 1994;37:300-307.
25. 2 receptor in dog skeletal muscle and rat L6 myoblasts. Eur J Endocrinol. 1998;138: 344-352.
26. Rett KM, Wicklmayr M, Dietze GJ, Häring HU. Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle is mimicked by bradykinin. Diabetes. 1996;45:866-869.
27. Cheatam B, Khan CR. Insulin action and the insulin signaling network. Endocr Rev. 1995;16:117-142.
28. Jacob SE, Henriksen EJ, Fogt DL, Dietze GJ. Effects of tradolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism. 1996;45:535-541.
29. Quinn LA, McCumbee D. Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol. 1998;177:94-102.
30. Baron AD, Clark MG. Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr. 1997;17:487-499.
31. Lender D, Arauz-Pacheco C, Adams-Huet B, Raskin P. Essential hypertension is associated with decreased insulin clearance and insulin resistance. Hypertension. 1997;29:111-114.
32. Ichikawa I, Maddox DA, Brenner BM. Maturational development of glomerular ultrafiltration in the rat. Am J Physiol. 1979;236: F465-F471.
33. Meland E, Laerum E, Aakvaag A, Ulvick RJ. Salt restriction and increased insulin production in hypertensive patients. Scand J Clin Lab Invest. 1994;54:405-409.
34. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75:473-486.
35. Sharma AM, Arntz HR, Kribben AS, Schattenfroh DA. Dietary sodium restriction: adverse effects on plasma lipids. Klin Wochenschr. 1990;68: 664-668.
36. Fliser D, Nowack R, Allendorf-Ostwald N. Kohl B, Hübinger A, Ritz E. Serum lipid changes on low salt - effect of alpha-1 adrenergic blockade. Am J Hypertens. 1993;6:320-324.
37. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46:3-10.